Patents by Inventor Akiko DOI

Akiko DOI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091381
    Abstract: Provided herein are nucleic acid trans-splicing molecules (e.g., pre-mRNA trans-splicing molecules (RTMs); RNA exon editing molecules) capable of correcting mutations in the ABCA4 gene. Such molecules are useful in the treatment of disorders such as ABCA4-associated retinal dystrophies (e.g., Stargardt Disease or cone-rod dystrophy). Also described herein are methods of using the nucleic acid trans-splicing molecules described herein to correct mutations in ABCA4, thereby treating disorders associated with mutations in ABCA4 and use of the nucleic acid trans-splicing molecules described herein for treating disorders associated with mutations in ABCA4 and in the preparation of medicaments for the treatment of disorders associated with mutations in ABCA4.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 21, 2024
    Inventors: Rebekka Krumbach, Scott Dooley, Akiko Doi, Kirk Burkhart, Jesse Gray, Lingtao Peng, Dennis Wu, Akiko Noma, Kirk Gosik, Shimyn Slomovic, Adam Clemens, Robert Bell
  • Publication number: 20240042057
    Abstract: Provided herein are nucleic acid trans-splicing molecules (e.g., pre-mRNA trans-splicing molecules (RTMs); RNA exon editing molecules) capable of correcting mutations in the ABCA4 gene. Such molecules are useful in the treatment of disorders such as ABCA4-associated retinal dystrophies (e.g., Stargardt Disease or cone-rod dystrophy). Also described herein are methods of using the nucleic acid trans-splicing molecules described herein to correct mutations in ABCA4, thereby treating disorders associated with mutations in ABCA4 and use of the nucleic acid trans-splicing molecules described herein for treating disorders associated with mutations in ABCA4 and in the preparation of medicaments for the treatment of disorders associated with mutations in ABCA4.
    Type: Application
    Filed: May 12, 2023
    Publication date: February 8, 2024
    Inventors: Rebekka Krumbach, Scott Dooley, Akiko Doi, Kirk Burkhart, Jesse Gray, Lingtao Peng, Dennis Wu, Akiko Noma, Kirk Gosik, Shimyn Slomovic, Adam Clemens, Robert Bell
  • Patent number: 10407543
    Abstract: A method for producing polyethylene glycol having a terminal carboxyl group including oxidizing polyethylene glycol represented by formula (I): CH3O(CH2CH2O)n(CH2)m—CHO with potassium peroxymonosulfate in water whose pH is adjusted to be from 6 to 8 with at least one selected from a carbonate, a phosphate, a citrate and an acetate at 5 to 40° C. to produce polyethylene glycol represented by formula (II): CH3O(CH2CH2O)n(CH2)m—COOH, wherein n is a number from 10 to 1,100, and m is 2 or 3.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: September 10, 2019
    Assignee: NOF CORPORATION
    Inventors: Akiko Doi, Takashi Ichikawa, Tsuyoshi Takehana, Takuma Tsubusaki
  • Publication number: 20190055353
    Abstract: A method for producing polyethylene glycol having a terminal carboxyl group including oxidizing polyethylene glycol represented by formula (I): CH3O(CH2CH2O)n(CH2)m—CHO with potassium peroxymonosulfate in water whose pH is adjusted to be from 6 to 8 with at least one selected from a carbonate, a phosphate, a citrate and an acetate at 5 to 40° C. to produce polyethylene glycol represented by formula (II): CH3O(CH2CH2O)n(CH2)m—COOH, wherein n is a number from 10 to 1,100, and m is 2 or 3.
    Type: Application
    Filed: November 17, 2016
    Publication date: February 21, 2019
    Applicant: NOF CORPORATION
    Inventors: Akiko DOI, Takashi ICHIKAWA, Tsuyoshi TAKEHANA, Takuma TSUBUSAKI